A
Andrew D. Ellington
Researcher at University of Texas at Austin
Publications - 599
Citations - 48723
Andrew D. Ellington is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Aptamer & RNA. The author has an hindex of 96, co-authored 569 publications receiving 43262 citations. Previous affiliations of Andrew D. Ellington include Harvard University & UPRRP College of Natural Sciences.
Papers
More filters
Book ChapterDOI
DNA Nanotechnology: From Biology and Beyond
Chunhua Liu,Andrew D. Ellington +1 more
TL;DR: This chapter summarizes recent development in DNA nanotechnology and addresses its potential applications in drug delivery, analysis and diagnosis, electronics, and photovoltaics.
Posted ContentDOI
Multiplex logic processing isothermal diagnostic assays for an evolving virus
Sanchita Bhadra,Miguel A. Saldaña,Haiyong Han,Grant L. Hughes,Grant L. Hughes,Andrew D. Ellington +5 more
TL;DR: The platform is demonstrated by using the same assay to detect divergent Asian and African lineages of the evolving Zika virus (ZIKV), while maintaining selectivity against non-target viruses.
Proceedings ArticleDOI
Aptamer-Based Lab-on-Chip for Cancer Cell Isolation and Detection
TL;DR: A novel epidermal growth factor receptor (EGFR) aptamer biochip is used to identify and isolate cancer cells that overexpress EGFR and these results provide a solid basis for the development of diagnostic devices that can readily identify and isolation CTCs.
Journal ArticleDOI
Synthesis and structural analyses of phenylethynyl-substituted tris(2-pyridylmethyl)amines and their copper(II) complexes
TL;DR: Three new tris(2-pyridylmethyl)amine-based ligands possessing phenylethynyl units have been prepared using Sonogashira couplings and substitution reactions and copper complexes of those tetradentate ligands showed a remarkably deformed carbon-carbon triple bond enforced by a steric effect of the three phenyl groups.